I would say the last call with NP calling out the shorts,
I would say the last call with NP calling out the shorts, he knows their intention and they were very careful not to give dates or signal anything to them. Past calls and PRs were used by many of the negative bashers as fuel for disinformation on boards. They are just making up lies about results, bringing up old news, they have no merit. Its just a bunch of noise, and stomping like children. I think CYDY knows they need to be very tactical now, and ensure they don't over communicate plans, and PRs need to be laser focused without fluff. What the last 30 days have demonstrated is that there is alot of support behind the science, long investors are holding, the SP is holding. there is no need for pointless update calls and coddling of retail investors like in the past. Drop real news when you have it, execute on actions, no pumping, no promotion stick to the script, leave the bashers as little as possible to attack.
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Papa John’s $2.7 Billion Takeover Bid: Insights into Potential Value Recently, shares of Papa John’s International Inc (NASDAQ:PZZA) experienced a notable surge, leading to a halt in trading due to high volatility. This surprising movement came in light of credible reports suggesting a take-private cash offer of $65 per share from TriArtisan Capital Advisors, totaling...
Continue Reading
Octopus Apollo VCT plc AGM Results Overview Octopus Apollo VCT plc recently conducted its Annual General Meeting (AGM), showcasing significant engagement from shareholders. The meeting aimed to discuss key resolutions impacting the future direction of the company. Voting Outcomes of the AGM The company disclosed that all resolutions were successfully passed during the...
Continue Reading
Carisma Therapeutics Showcases Strong Financial Performance Carisma Therapeutics Inc. (NASDAQ: CARM), a clinical-stage biopharmaceutical company, recently released its financial performance for the third quarter of 2024. With a focus on developing innovative immunotherapies, Carisma provided insight into its ongoing projects. Key Developments and Milestones Carisma's...
Continue Reading
Overview of the Epinephrine Market The global epinephrine market is on a significant upswing, with recent evaluations estimating its value at USD 3.11 billion and a projected growth to approximately USD 6.39 billion within the next decade. As a critical hormone and neurotransmitter produced by the adrenal glands, epinephrine is essential in treating severe allergic...
Continue Reading
Canadian North Resources Makes Significant Progress in Operational Strategy Highlights: Canadian North has expanded its bio-metallurgical programs significantly, achieving impressive nickel and cobalt extraction rates through innovative bio-leaching tests. The focus remains on extracting copper and other precious group elements (PGE) metals from the Ferguson Lake Project....
Continue Reading
